- Home
- LFCR vs CBUS Comparison
LFCR vs CBUS Comparison
Compare LFCR & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LFCR | CBUS |
|---|---|---|
| Founded | 1986 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 143.9M | 121.1M |
| IPO Year | 1996 | 2017 |
Fundamental Metrics
Financial Performance| Metric | LFCR | CBUS |
|---|---|---|
| Price | $4.97 | $1.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $5.50 | ★ $9.00 |
| AVG Volume (30 Days) | 324.5K | ★ 631.2K |
| Earning Date | 08-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 74.33 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $557,559,000.00 | $3,639,000.00 |
| Revenue This Year | N/A | $112.72 |
| Revenue Next Year | $5.04 | $83.18 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 6.36 | N/A |
| 52 Week Low | $3.63 | $1.09 |
| 52 Week High | $8.98 | $4.19 |
Technical Indicators
Market Signals| Indicator | LFCR | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 47.78 | 32.82 |
| Support Level | $3.63 | $1.19 |
| Resistance Level | $5.53 | $1.54 |
| Average True Range (ATR) | 0.29 | 0.13 |
| MACD | 0.07 | 0.04 |
| Stochastic Oscillator | 36.97 | 11.27 |
Price Performance
Historical ComparisonAbout LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.